CXCR3 and COVID-19: Moreover, although our study focused on mRNA COVID-19 vaccines, another recent study found the Ad26.COV2.S, elicited more CXCR3+ BSM without atMBC features compared to mRNA vaccines5, suggesting similar cells may be generated by viral vaccine platforms.